Soutenir la recherche

Actualités

European Association for the Study of the Liver 2018

11 avril 2018

Présentations orales


Mercredi 11/04/2018

  • 8h00-11h00 RESEARCH THINK TANK: VIRAL HEPATITIS J-M. PAWLOTSKY
  • 12H30-13H30 POST-GRADUATE COURSE-HCV J-M. PAWLOTSKY
  • 12H45-13H00 DIFFICULT-TO-CURE PATIENTS IN 2018 C. HEZODE

Jeudi 12/04/2018

  • 10H30-12H00 POST-GRADUATE COURSE-HCV J-M. PAWLOTSKY
  • 17H30-18H00 THINK-TANK SESSION DEBRIEF J-M. PAWLOTSKY

Vendredi 13/04/2018

  • 11H30-12H30 MEET-THE-EXPERT: DIFFICULT CASES OF HCV THERAPY: IS THERE ANY ? J-M. PAWLOTSKY
  • 17H30-18H00 DIRECT-ACTING ANTIVIRALS FOR CHRONIC HEPATITIS C J-M. PAWLOTSKY
  • 18H30-20H00 ABBVIE: HCV UNSYMPOSIUM J-M. PAWLOTSKY

Samedi 14/04/2018

  • 10H30-12H30 KIRBY: HCV DIAGNOSTICS SYMPOSIUM J-M. PAWLOTSKY
  • 18H30-19H30 EASL RECOMMENDATIONS ON TREATMENT OF HEPATITIS C 2018 J-M. PAWLOTSKY

Dimanche 15/04/2018

  • 08H30-08H50 VIRAL HEPATITIS C. HEZODE

Posters


THU-300 (12/04/2018)

Sofosbuvir plus ribavirin and sofosbuvir plus daclatasvir-based regimens are suboptimal in genotype 2 patients: real-life experience from the Hepather ANRSCO22 cohort.
C. HEZODE
, V. de LEDINGHEN, G. HAOUR, J.P. BRONOWICKI, F. ZOULIM, D. LARREY, S. METIVIER, A. TRAN, P. MARCELLIN, D. SAMUEL, O. CHAZOUILLERES, S. CHEVALIEZ C. DORIVAL, H. FONTAINE, J.-M. PAWLOTSKY, F. CARRAT, S. POL, on the behalf of the AFEF/ANRS study group. EASL

THU-301 (12/04/2018)

Efficacy and safety of Elbasvir/Grazoprevir in women infected with hepatitis C virus genotype 1 or 4 and co-administered oral contraceptives or hormone replacement therapy
C. HEZODE, P. KWO, J. SPERL, G. DORE, P. HWANG, J. LONG, R. TALWANI, M. ROBERTSON, B. HABER

THU-332 (12/04/2018)

Characteristics and retreatment of HCV DAA failure patients: Real-life experience.
I. RUIZ, S. FOURATI, A. VARAUT, G. SCOAZEC, M. FRANCOIS, M. WLASSOW, L. POITEAU, F. DONATI, A. SOULIER, S. CHEVALIEZ, A. MALLAT, J.-M. PAWLOTSKY, C. HEZODE

FRI-024 YI (13/04/2018)

Short-term suvival after liver transplantation depends on the matching of graft and recipient caracteristics
E. LEVESQUE, E. AUDUREAU, A. WINTER, C. ANTOINE, J.P. DAURES, P. LANDAIS, D. AZOULAY, C. DUVOUX, C. FERAY, O. Group.

FRI-025 YI (13/04/2018)

Rescue allocationin the french nationwide liver graft cohort
C. FERAY, A. WINTER, M. DISABATO, P. COMPAGNON, C. JACQUELINET, J.P. DAURES, D. AZOULAY, P. LANDAIS, O. Group.

FRI-141 (13/04/2018)

Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance
M. ZIOL, N. POTE, G. AMADDEO, A. LAURENT, J.C. NAULT, F. OBERTI, C. COSTENTIN, S. MICHALAK, B. MOHAMED, C. FRANCOZ, G.-P. PAGEAUX, J. RAMOS, D. THOMAS, A. LUCIANI, B. GUIU, V. VILGRAIN, C. AUBE, J. DERMAN, C. CHARPY, J. ZUCMAN-ROSSI, N. BARGET, O. SEROR, N. GANNE-CARRIE, V. PARADIS, J. CALDERARO

FRI-502 (13/04/2018)

Proof-of-concept of shotgun metagenomic sequencing as diagnostic tool for diagnosis of acute viral hepatitis.
I. RUIZ, G. GRICOURT, S. FOURATI, S. CHEVALIEZ, A. LE BOUTER, H. REGNAULT, V. DEMONTANT, F. LE GAL, E. GORDIEN, C. HEZODE, C. RODRIGUEZ, J.-M. PAWLOTSKY.

SAT-339 (14/04/2018)

Longitudinal analysis of HCV full genomes in patients failing NS5Ainhibitors reveals the selection of novel amino acid substitutions outside NS5A
S. FOURATI, C. RODRIGUEZ, A. SOULIER, L. POITEAU, D. VANESSA, I. RUIZ, C. HEZODE, S. CHEVALIEZ, J.-M. PAWLOTSKY

SAT-391 (14/04/2018)

Molecular diversity of HDV strains that spread in France: a study of 2224 clinical strains prospectively collected during fifteen years
A. GERBER, F. LE GAL, S. DZIRI, C. ALLOUI, D. ROULOT, Z. BEN ABDESSELAM, S. BRICHLER, E.GORDIEN

SAT-392 (14/04/2018)

Molecular diversity of HBV and HDV amino-acid sequences involved in HDV virion morphogenesis according to HBV and HDV genotypes: study of 1590 clinical strains
A. GERBER, S. DZIRI, S. BRICHLER, C. ALLOUI, D. ROULOT, Z. BEN ABDESSELAM, F. LE GAL, E. GORDIEN

 

EASL - 11-15 avril 2018 - Paris

Précédent Toutes les actualités Suivant